admin

About admin

VANCOUVER, B.C., CANADA (January 26, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today that it has repriced from $0.50 to $0.05 per share 4,375,000 options expiring on February 6 and 1,025,000 options expiring on February 13, 2017. The Company also announced that it has issued stock [...]

VANCOUVER, B.C., CANADA (January 24, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today as part of its planned acquisition of 40 J’s, that it will immediately seek marketing and distribution partnerships for the patented and proprietary topical products for the relief of menopausal symptoms that will [...]

M Pharmaceutical Inc. Announces Strategy To Seek Distribution Partners For Their Patented Technologies To Deliver Phytoestrogens For The Treatment Of The Symptoms Of Menopause admin
2017-07-31T10:41:35+00:00

VANCOUVER, B.C., CANADA (January 19, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today as part of its planned acquisition of Cincinnati based 40 J’s, that it will immediately transition all products to paraben-free formulations based on an exclusive license it is acquiring for an innovative, patent [...]

VANCOUVER, B.C., CANADA (January 10, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today that the Company is moving to build significant infrastructure, perform additional product R&D and focus on international business expansion to increase the level of sales currently achieved by the current owner of their [...]

A Canadian drug company with a Fort Thomas subsidiary that makes products aimed at treating obesity and infertility has purchased a small Cincinnati biotech company working on drugs to address female sexual dysfunction. M Pharmaceutical Inc. of Vancouver, British Columbia, is acquiring 40 J’s LLC of Turpin Hills in exchange for $1.5 million in [...]

VANCOUVER, B.C., CANADA (January 4, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), is announcing today that the company has executed on a Letter of Intent to acquire the assets of Cincinnati based private research and development partnership 40J’s LLC (and related companies & technologies). In return for [...]